Posted on

mor cream cbd for pain

*750MG of TRC CBD per tube – The efficacy has been tested by 15 Dentists on over 40 patients collectively. The feedback from these patients is that it reduces the pain they have been experiencing from having temporomandibular joint (TMJ) disorder. On a 0 to 10 pain scale with 10 being the worst the range of pain before using TRC was between 7-10 and after using TRC their pain range was between 1-3. The relief was felt within minutes up to a couple hours.

The power of CBD pain relief comes to dentistry. Tested by dentists for dentists. TRC is a safe and holistic alternative to manage TMJ and neck pain associated with:

Add to your post-procedure care kit or prescribe individually.

When it comes to prescribing targeted relief,
think out of the box!

** Recent research shows that transdermal CBD, a known non-psychoactive cannabinoid, has efficacy in diminishing pain and inflammation through pro-neurogenic effects and by reducing pro-inflammatory cytokines. These studies have demonstrated that transdermal CBD has long-lasting therapeutic effects without psychoactive side-effects. Transdermal CBD is safe and offers a relatively benign pharmacological method of treatment.

Sterngold is your Source for Restorative Dentistry Products and a Global Leader in Alloys, Attachments, Implants, and Consumables.

1 mg/kg CBDA). Dogs were then dosed every 12 h for 2 weeks and had further serum analyses at weeks 1 and 2, 6 h after the morning dose to assess serum cannabinoids. Serum was analyzed for each cannabinoid or cannabinoid metabolite using liquid chromatography and tandem mass spectroscopy (LC-MS/MS). Regardless of the form provided (1, 2, or 3) the 24-h pharmacokinetics for CBD, CBDA, and THCA were similar, with only Form 2 generating enough data above the lower limit of quantitation to assess pharmacokinetics of THC. CBDA and THCA concentrations were 2- to 3-fold higher than CBD and THC concentrations, respectively. The 1- and 2-week steady-state concentrations were not significantly different between the two oils or the soft chew forms. CBDA concentrations were statistically higher with Form 2 than the other forms, showing superior absorption/retention of CBDA. Furthermore, Form 1 showed less THCA retention than either the soft chew Form 3 or Form 2 at weeks 1 and 2. THC was below the quantitation limit of the assay for nearly all samples. Overall, these findings suggest CBDA and THCA are absorbed or eliminated differently than CBD or THC, respectively, and that a partial lecithin base provides superior absorption and/or retention of CBDA and THCA.